Raya Therapeutic announces supportive clinical results of fasudil in amyotrophic lateral sclerosis patients

First Patient Dosed in the MAD Part 2 Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

drugs.com - 26/Jun 19:06

CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic...

Synaptogenix gets US FDA authorization of IND application for clinical trial for Bryostatin─1 to treat multiple sclerosis

pharmabiz.com - 00:00

Synaptogenix, Inc., an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, announced that the Food & Drug...

Aethlon Medical receives HREC's approval for Hemopurifier cancer trial

pharmabiz.com - 20/Jun 00:00

Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life─threatening infectious diseases,...

PTC Therapeutics announces interim results from phase 2 PIVOT─HD study of PTC518 in Huntington's disease patients

pharmabiz.com - 22/Jun 00:00

PTC Therapeutics, Inc, a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated...

Blood test identifies specific pathologies in frontotemporal dementia, ALS, and PSP

news.medical.net - 18/Jun 16:49

In a study with 991 adults, scientists at DZNE show that the most common forms of frontotemporal dementia (FTD) as well as the neurological diseases...

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation Granted to SLS009 for the Treatment of Pediatric Acute Lymphoblastic Leukemia

drugs.com - 24/Jun 23:06

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a...

Mozart Therapeutics Doses First Cohort of Participants in Phase 1a/b Clinical Trial of MTX-101, in Development for Treatment of Autoimmune Diseases

drugs.com - 17/Jun 22:06

SEATTLE, June 17, 2024. Mozart Therapeutics, a clinical stage biopharmaceutical company focused on the development of CD8 Treg modulators in...

Palatin Announces the Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered with a PDE5i for the Treatment of Erectile Dysfunction

drugs.com - 21/Jun 03:06

CRANBURY, N.J., June 20, 2024. Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class medicines based on molecules that...

Sarepta Therapeutics Announces Expanded US FDA Approval of Elevidys to Duchenne Muscular Dystrophy Patients Ages 4 and Above

drugs.com - 20/Jun 23:06

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 20, 2024-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...

Bamyan Provincial Hospital sans ear, throat treatment facility

pajhwok.com - 29/Jun 12:09

Some residents in central Bamyan province have complained about the non-availability of ear and throat diseases treatment facility and said patients...

Rubriques :